Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer.
Koscielny
S
S
ENT-Department Friedrich-Schiller-University, Jena, Germany.
Dahse
R
R
Sonntag
J
J
Riese
U
U
Theuer
C
C
Hofmann
M E
ME
von Eggeling
F
F
Claussen
U
U
Beleites
E
E
Ernst
G
G
Fiedler
W
W
D018450:Disease Progression; D016147:Genes, Tumor Suppressor / Q000235:genetics; D019942:Genes, p16 / Q000235:genetics*; D006258:Head and Neck Neoplasms / Q000201:enzymology* / Q000235:genetics*; D006801:Humans; D011379:Prognosis; D019098:Telomerase / Q000235:genetics* / Q000378:metabolism*
D019098:Telomerase